Classification of diabetic nephropathy 2014

Masakazu Haneda; Kazunori Utsunomiya; Daisuke Koya; Tetsuya Babazono; Tatsumi Moriya; Hirofumi Makino; Kenjiro Kimura; Yoshiki Suzuki; Takashi Wada; Susumu Ogawa; Masaaki Inaba; Yoshihiko Kanno; Takashi Shigematsu; Ikuto Masakane; Ken Tsuchiya; Keiko Honda; Kazuko Ichikawa; Kenichiro Shide

Classification of diabetic nephropathy 2014

Masakazu Haneda, Kazunori Utsunomiya, Daisuke Koya, Tetsuya Babazono, Tatsumi Moriya, Hirofumi Makino, Kenjiro Kimura, Yoshiki Suzuki, Takashi Wada, Susumu Ogawa, Masaaki Inaba, Yoshihiko Kanno, Takashi Shigematsu, Ikuto Masakane, Ken Tsuchiya, Keiko Honda, Kazuko Ichikawa, Kenichiro Shide

Medical School

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 ml/min/1.73 m², regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages.

Original language	English
Pages (from-to)	529-534
Number of pages	6
Journal	Journal of the Japan Diabetes Society
Volume	57
Issue number	7
Publication status	Published - 2014

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{f5f6548d4b5a43529ca4879ba01fd3d0,

title = "Classification of diabetic nephropathy 2014",

abstract = "The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 ml/min/1.73 m2, regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages.",

author = "Masakazu Haneda and Kazunori Utsunomiya and Daisuke Koya and Tetsuya Babazono and Tatsumi Moriya and Hirofumi Makino and Kenjiro Kimura and Yoshiki Suzuki and Takashi Wada and Susumu Ogawa and Masaaki Inaba and Yoshihiko Kanno and Takashi Shigematsu and Ikuto Masakane and Ken Tsuchiya and Keiko Honda and Kazuko Ichikawa and Kenichiro Shide",

year = "2014",

language = "English",

volume = "57",

pages = "529--534",

journal = "Journal of the Japan Diabetes Society",

issn = "0021-437X",

publisher = "Japan Diabetes Society",

number = "7",

}

TY - JOUR

T1 - Classification of diabetic nephropathy 2014

AU - Haneda, Masakazu

AU - Utsunomiya, Kazunori

AU - Koya, Daisuke

AU - Babazono, Tetsuya

AU - Moriya, Tatsumi

AU - Makino, Hirofumi

AU - Kimura, Kenjiro

AU - Suzuki, Yoshiki

AU - Wada, Takashi

AU - Ogawa, Susumu

AU - Inaba, Masaaki

AU - Kanno, Yoshihiko

AU - Shigematsu, Takashi

AU - Masakane, Ikuto

AU - Tsuchiya, Ken

AU - Honda, Keiko

AU - Ichikawa, Kazuko

AU - Shide, Kenichiro

PY - 2014

Y1 - 2014

N2 - The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 ml/min/1.73 m2, regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages.

AB - The Committee on Diabetic Nephropathy revised the classification of diabetic nephropathy in view of the current status of eGFR and CKD in Japan. To make revisions for the classification of diabetic nephropathy 2014, the Committee carefully evaluated the report of the Research Group on Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan. The major revisions made were as follows: 1. eGFR can be used for the evaluation of GFR; 2. In stage 3 (overt nephropathy), A and B were combined; 3. Stage 4 (renal failure) was defined as GFR less than 30 ml/min/1.73 m2, regardless of albuminuria; and 4. The importance of differential diagnosis was stressed in all stages.

UR - http://www.scopus.com/inward/record.url?scp=84906561530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906561530&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84906561530

SN - 0021-437X

VL - 57

SP - 529

EP - 534

JO - Journal of the Japan Diabetes Society

JF - Journal of the Japan Diabetes Society

IS - 7

ER -

Classification of diabetic nephropathy 2014

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this